George G Nomikos
Keine laufenden Positionen mehr
Karriereverlauf von George G Nomikos
Ehemalige bekannte Positionen von George G Nomikos
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LIPOCINE INC. | Technik-/Wissenschafts-/F&E-Leiter | 03.11.2022 | 01.04.2023 |
| SCHOLAR ROCK HOLDING CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 05.09.2019 | 02.11.2022 |
| AMGEN INC. | Corporate Officer/Principal | 01.10.2007 | 01.10.2007 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.2006 | 01.01.2006 |
| Karolinska Institutet | Corporate Officer/Principal | - | - |
| CYNAPSUS THERAPEUTICS INC | Technik-/Wissenschafts-/F&E-Leiter | 30.10.2007 | - |
Ausbildung von George G Nomikos
| National & Kapodistrian University of Athens | Doctorate Degree |
| University of British Columbia | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Kanada | 3 |
| Griechenland | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| AMGEN INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| LIPOCINE INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Cynapsus Therapeutics, Inc.
 Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada. | Health Technology |
- Börse
- Insiders
- George G Nomikos
- Erfahrung
